drugset / Trial / NCT03631420
Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants
NaSingle-groupOpen-labelPrevention
Summary
The clinical study with UMC119-01 is designed to investigate the safety in patients with bronchopulmonary dysplasia ("BPD"). This will be a dose escalation, open-label, single-center study in infants at high risk for BPD.
Timeline
- Start
- 2018-10-26
- Primary completion
- 2025-12-31
- Completion
- 2027-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | human umbilical cord mesenchymal stem cells | Cell therapy | 3 cells/kg | — |
| Subject | human umbilical cord mesenchymal stem cells | Cell therapy | 10 cells/kg | — |
| Subject | human umbilical cord mesenchymal stem cells | Cell therapy | 30 cells/kg | — |